Patent · US Expired

Stabilized pharmaceutical peptide compositions

US5482931A · kind A · utility

76Cited by
12References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 1993
Grant dateJan 9, 1996
Priority date
Expiry dateJun 29, 2013

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/095
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a stabilized aqueous composition for administration to a patient comprising a biologically active peptide, a buffer, a quaternary amine-type preservative or disinfectant, and an osmotic pressure-controlling agent, which composition can be stored and used at room temperature. The buffer stabilizes the pH of the composition between about 4 and 6. The preferred buffer contains citrate and/or phosphate, and the preferred preservative or disinfectant is benzalkonium chloride. The composition protects the peptide contained therein from adhering to container surfaces, particularly in containers made of polymeric materials.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.